ALADDIN SCIENTIFIC
Gentle quillaja adjuvant (C008B-268480)
I. Product PositioningCore CharacteristicsMild Saponin Aqueous Adjuvant is a highly purified, concentrated saponin adjuvant that can also serve as a universal immune enhancer.
I. Product PositioningCore CharacteristicsMild Saponin Aqueous Adjuvant is a highly purified, concentrated saponin adjuvant that can also serve as a universal immune enhancer. It appears as a pale yellow or amber clear transparent liquid, with highly purified immunologically active substances as the main component and a pH value of 4.0–6.5. It is safe, non-toxic and metabolizable, effectively induces immune responses in the body, exhibits strong immune effects against both T-cell-dependent and T-cell-independent antigens, and produces a remarkable mucosal immune response.Technical Breakthroughs1. Raw Material Innovation: Through raw material screening, a standardized raw material grading system has been established, with batch-to-batch consistency CV < 3%.2. Process Upgrading: A new technical route for saponin production is adopted, resulting in higher saponin purity and a 50% cost reduction compared with imported products.II. Technical ParametersItemDescriptionSourceExtracted from the bark of Quillaja saponaria (South American soapbark tree)Saponin Purity≥90% (HPLC area normalization method)Key ComponentsMild saponins, surfactantsEndotoxin Control≤10 EU/mLShelf Life2 years (stored at 2–8 °C, protected from light)III. Mechanism of ActionDual Pathway Immune Activation1. Innate Immune ActivationMild Saponin Aqueous Adjuvant is derived from the water-soluble saponin fraction of Quillaja saponaria Molina, belonging to triterpenoid saponins with a common triterpene skeleton structure. It exerts potent adjuvant effects on both T-cell-dependent and T-cell-independent antigens, significantly enhances CD8⁺ cytotoxic lymphocyte responses, and boosts mucosal antigen immune responses.Mild Saponin Aqueous Adjuvant enhances the differentiation and proliferation of immune cells in immune organs. By increasing the number of innate immune cells, promoting their differentiation and maturation, reducing the expression of immunosuppressive molecules, and stimulating the proliferation of immune effector cells, it exerts an immune-enhancing effect. Meanwhile, the adjuvant and antigen enter antigen-presenting cells via endocytosis. Following endosomal membrane disruption mediated by the adjuvant, the degraded protein antigens are further processed into smaller peptide fragments in the cytosol through the proteasome pathway. The degraded peptides are translocated into the endoplasmic reticulum via transporter molecules, where they facilitate binding to newly synthesized MHC class I molecules, which then migrate to the cell surface via Golgi vesicles. Finally, peptide epitopes associated with MHC class I molecules exposed on the surface of DCs (dendritic cells) are presented to naive CD8⁺ T cells via the T-cell receptor (cross-presentation), providing co-stimulatory signals, secreting cytokines, and triggering an immune response.Safety Advantages1. Low-Toxicity Design: Highly allergenic impurities such as polysaccharides, polyphenols and tannins are removed (removal rate ≥95%).2. Acute oral toxicity in rats: LD₅₀ > 5000 mg/kg b.w., EPA Toxicity Category IV.3. Acute dermal toxicity in rats: LD₅₀ > 4000 mg/kg b.w.IV. Verified Application ScenariosVeterinary VaccinesDisease AreaVaccine ExampleEfficacy DataFoot-and-Mouth DiseaseSwine Type O FMDV Inactivated Vaccine + Saponin2.8-fold increase in antibody GMT compared with conventional aluminum gel adjuvantPRRSVUS AMERCAV Vaccine + Saponin99% reduction in viral load after challenge (detected by qPCR)FascioliasisMultiepitope Peptide Vaccine for Sheep + Saponin83% reduction in fecal egg count (Kato-Katz method)ToxoplasmosisSAG1 Recombinant Protein Vaccine + Saponin76% decrease in brain cyst formation rate (histopathological scoring)Pet Vaccines1. Feline Calicivirus (FCV): Antibody positive rate increased from 68% to 94% (detected by ELISA).2. Canine Parvovirus (CPV): Survival rate improved by 40% (challenge protection test).V. Quality Advantages & ComplianceQuality Control System1. Raw Material Stage(1) Heavy metal control: As ≤ 2 ppm, Hg ≤ 0.2 ppm, complying with USP <232>.(2) Endotoxin: ≤ 5 EU/mg.(3) Pesticide residue control, complying with the standards of the Chinese Pharmacopoeia.2. Production Stage(1) Full-process traceability (batch records linked to raw material source and extraction parameters).(2) Formulation process preserves saponin activity (activity recovery rate > 95%).VI. Recommended Application ProtocolCompatible Vaccine TypesRecommended Dosage: The content of the main active ingredient in Mild Saponin Aqueous Adjuvant is 1.0 mg/mL. The recommended addition levels vary according to the vaccinated animals and immune dosage as follows:Animal SpeciesMouseGuinea PigRabbitSwine, SheepCattleMaximum Single Dose≤15 μg/dose≤25 μg/dose≤50 μg/dose≤300 μg/dose≤750 μg/doseRecommended Dosage10 μg/dose20 μg/dose40 μg/dose200 μg/dose500 μg/dose
Specifications & Purity: I. Product PositioningCore CharacteristicsMild Saponin Aqueous Adjuvant is a highly purified, concentrated saponin adjuvant that can also serve as a universal immune enhancer. It appears as a pale yellow or amber clear transparent liquid, with highly purified immunologically active substances as the main component and a pH value of 4.0–6.5. It is safe, non-toxic and metabolizable, effectively induces immune responses in the body, exhibits strong immune effects against both T-cell-dependent and T-cell-independent antigens, and produces a remarkable mucosal immune response.Technical Breakthroughs1. Raw Material Innovation: Through raw material screening, a standardized raw material grading system has been established, with batch-to-batch consistency CV < 3%.2. Process Upgrading: A new technical route for saponin production is adopted, resulting in higher saponin purity and a 50% cost reduction compared with imported products.II. Technical ParametersItemDescriptionSourceExtracted from the bark of Quillaja saponaria (South American soapbark tree)Saponin Purity≥90% (HPLC area normalization method)Key ComponentsMild saponins, surfactantsEndotoxin Control≤10 EU/mLShelf Life2 years (stored at 2–8 °C, protected from light)III. Mechanism of ActionDual Pathway Immune Activation1. Innate Immune ActivationMild Saponin Aqueous Adjuvant is derived from the water-soluble saponin fraction of Quillaja saponaria Molina, belonging to triterpenoid saponins with a common triterpene skeleton structure. It exerts potent adjuvant effects on both T-cell-dependent and T-cell-independent antigens, significantly enhances CD8⁺ cytotoxic lymphocyte responses, and boosts mucosal antigen immune responses.Mild Saponin Aqueous Adjuvant enhances the differentiation and proliferation of immune cells in immune organs. By increasing the number of innate immune cells, promoting their differentiation and maturation, reducing the expression of immunosuppressive molecules, and stimulating the proliferation of immune effector cells, it exerts an immune-enhancing effect. Meanwhile, the adjuvant and antigen enter antigen-presenting cells via endocytosis. Following endosomal membrane disruption mediated by the adjuvant, the degraded protein antigens are further processed into smaller peptide fragments in the cytosol through the proteasome pathway. The degraded peptides are translocated into the endoplasmic reticulum via transporter molecules, where they facilitate binding to newly synthesized MHC class I molecules, which then migrate to the cell surface via Golgi vesicles. Finally, peptide epitopes associated with MHC class I molecules exposed on the surface of DCs (dendritic cells) are presented to naive CD8⁺ T cells via the T-cell receptor (cross-presentation), providing co-stimulatory signals, secreting cytokines, and triggering an immune response.Safety Advantages1. Low-Toxicity Design: Highly allergenic impurities such as polysaccharides, polyphenols and tannins are removed (removal rate ≥95%).2. Acute oral toxicity in rats: LD₅₀ > 5000 mg/kg b.w., EPA Toxicity Category IV.3. Acute dermal toxicity in rats: LD₅₀ > 4000 mg/kg b.w.IV. Verified Application ScenariosVeterinary VaccinesDisease AreaVaccine ExampleEfficacy DataFoot-and-Mouth DiseaseSwine Type O FMDV Inactivated Vaccine + Saponin2.8-fold increase in antibody GMT compared with conventional aluminum gel adjuvantPRRSVUS AMERCAV Vaccine + Saponin99% reduction in viral load after challenge (detected by qPCR)FascioliasisMultiepitope Peptide Vaccine for Sheep + Saponin83% reduction in fecal egg count (Kato-Katz method)ToxoplasmosisSAG1 Recombinant Protein Vaccine + Saponin76% decrease in brain cyst formation rate (histopathological scoring)Pet Vaccines1. Feline Calicivirus (FCV): Antibody positive rate increased from 68% to 94% (detected by ELISA).2. Canine Parvovirus (CPV): Survival rate improved by 40% (challenge protection test).V. Quality Advantages & ComplianceQuality Control System1. Raw Material Stage(1) Heavy metal control: As ≤ 2 ppm, Hg ≤ 0.2 ppm, complying with USP <232>.(2) Endotoxin: ≤ 5 EU/mg.(3) Pesticide residue control, complying with the standards of the Chinese Pharmacopoeia.2. Production Stage(1) Full-process traceability (batch records linked to raw material source and extraction parameters).(2) Formulation process preserves saponin activity (activity recovery rate > 95%).VI. Recommended Application ProtocolCompatible Vaccine TypesRecommended Dosage: The content of the main active ingredient in Mild Saponin Aqueous Adjuvant is 1.0 mg/mL. The recommended addition levels vary according to the vaccinated animals and immune dosage as follows:Animal SpeciesMouseGuinea PigRabbitSwine, SheepCattleMaximum Single Dose≤15 μg/dose≤25 μg/dose≤50 μg/dose≤300 μg/dose≤750 μg/doseRecommended Dosage10 μg/dose20 μg/dose40 μg/dose200 μg/dose500 μg/dose
Storage Temperature: Store at 2-8°C;Protected from light
Shipped in: Wet ice
- UPC:
- 51102842
- Weight:
- 1.23 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- S1520823-5ml
- Country of Origin:
- China
- Product Size:
- 5ml
- Harmonized Tariff Code:
- 2931.90.90



